Using oncolytic viruses (OVs) in combination with nanomaterials as a novel approach to cancer treatment.
Lowering the Target for Blood Pressure Is Best, Study Affirms
PHILADELPHIA — A systolic blood pressure treatment target under 120 mm Hg improved outcomes and saved lives compared with a threshold of 140 mm Hg